Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michel Meignan

Showing results (41-50 of 125) with videos related to

Pageof 13
Sort By:
Blood|January 22, 2020
Baseline SUVmax did not predict histological transformation in follicular lymphoma in the phase 3 GALLIUM studyFarheen Mir, Sally F Barrington, Helen Brown, et al.
Nuclear Medicine Communications|May 29, 2004
Quantitative lung perfusion scan as a predictor of aerosol distribution heterogeneity and disease severity in children with cystic fibrosisEmmanuel Itti, Brigitte Fauroux, Jérôme Pigeot, et al.
Current Hematologic Malignancy Reports|June 23, 2012
Early interim PET scans in diffuse large B-cell lymphoma: can there be consensus about standardized reporting, and can PET scans guide therapy choices?Rene-Olivier Casasnovas, Michel Meignan, Alina Berriolo-Riedinger, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 18, 2009
Prognostic value of interim 18F-FDG PET in patients with diffuse large B-Cell lymphoma: SUV-based assessment at 4 cycles of chemotherapyEmmanuel Itti, Chieh Lin, Jehan Dupuis, et al.
Nuclear Medicine Communications|November 3, 2005
FDG PET in patients with cancer of an unknown primaryHélène Kolesnikov-Gauthier, Eric Levy, Pascal Merlet, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 3, 2016
Molecular Profile and FDG-PET Metabolic Volume at Staging in DLBCL-ResponseAnne-Ségolène Cottereau, Hélène Lanic, Sylvain Mareschal, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 23, 2017
Staging, Restaging, and Treatment Response Assessment in Lymphomas: What We Should KnowSalim Kanoun, Anne-Segolène Cottereau, Alina Berriolo-Riedinger, et al.
Intensive Care Medicine|May 28, 2003
Effect of partial liquid ventilation on bacterial clearance during Pseudomonas aeruginosa-induced lung injury in ratsSaïda Rezaiguia-Delclaux, Kun Yang, François Stephan, et al.
Critical Care Medicine|March 13, 2002
Beneficial effects of nitric oxide inhalation on pulmonary bacterial clearanceDaniel Jean, Bernard Maître, Jacques Tankovic, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2016
Molecular Profile and FDG-PET/CT Total Metabolic Tumor Volume Improve Risk Classification at Diagnosis for Patients with Diffuse Large B-Cell LymphomaAnne-Ségolène Cottereau, Hélène Lanic, Sylvain Mareschal, et al.
Pageof 13

Showing results (41-50 of 125) with videos related to

Sort By:
Pageof 13
Blood|January 22, 2020
Baseline SUVmax did not predict histological transformation in follicular lymphoma in the phase 3 GALLIUM studyFarheen Mir, Sally F Barrington, Helen Brown, et al.
Nuclear Medicine Communications|May 29, 2004
Quantitative lung perfusion scan as a predictor of aerosol distribution heterogeneity and disease severity in children with cystic fibrosisEmmanuel Itti, Brigitte Fauroux, Jérôme Pigeot, et al.
Current Hematologic Malignancy Reports|June 23, 2012
Early interim PET scans in diffuse large B-cell lymphoma: can there be consensus about standardized reporting, and can PET scans guide therapy choices?Rene-Olivier Casasnovas, Michel Meignan, Alina Berriolo-Riedinger, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 18, 2009
Prognostic value of interim 18F-FDG PET in patients with diffuse large B-Cell lymphoma: SUV-based assessment at 4 cycles of chemotherapyEmmanuel Itti, Chieh Lin, Jehan Dupuis, et al.
Nuclear Medicine Communications|November 3, 2005
FDG PET in patients with cancer of an unknown primaryHélène Kolesnikov-Gauthier, Eric Levy, Pascal Merlet, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 3, 2016
Molecular Profile and FDG-PET Metabolic Volume at Staging in DLBCL-ResponseAnne-Ségolène Cottereau, Hélène Lanic, Sylvain Mareschal, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 23, 2017
Staging, Restaging, and Treatment Response Assessment in Lymphomas: What We Should KnowSalim Kanoun, Anne-Segolène Cottereau, Alina Berriolo-Riedinger, et al.
Intensive Care Medicine|May 28, 2003
Effect of partial liquid ventilation on bacterial clearance during Pseudomonas aeruginosa-induced lung injury in ratsSaïda Rezaiguia-Delclaux, Kun Yang, François Stephan, et al.
Critical Care Medicine|March 13, 2002
Beneficial effects of nitric oxide inhalation on pulmonary bacterial clearanceDaniel Jean, Bernard Maître, Jacques Tankovic, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2016
Molecular Profile and FDG-PET/CT Total Metabolic Tumor Volume Improve Risk Classification at Diagnosis for Patients with Diffuse Large B-Cell LymphomaAnne-Ségolène Cottereau, Hélène Lanic, Sylvain Mareschal, et al.
Pageof 13